These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 17353652)
1. Lack of association between body-mass index and white-coat hypertension among referred patients. Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652 [TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"]. Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654 [TBL] [Abstract][Full Text] [Related]
3. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index. Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516 [TBL] [Abstract][Full Text] [Related]
4. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring. Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890 [TBL] [Abstract][Full Text] [Related]
5. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079 [TBL] [Abstract][Full Text] [Related]
7. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [TBL] [Abstract][Full Text] [Related]
8. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525 [TBL] [Abstract][Full Text] [Related]
9. Determinants of the white-coat effect in hypertensive subjects. Mansoor GA; McCabe EJ; White WB J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561 [TBL] [Abstract][Full Text] [Related]
10. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care]. Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850 [TBL] [Abstract][Full Text] [Related]
11. White coat effect in treated hypertensive patients: sex differences. Myers MG; Reeves RA J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486 [TBL] [Abstract][Full Text] [Related]
12. Assessment of blood pressure control in hypertensive stroke survivors: an ambulatory blood pressure monitoring study. Zakopoulos N; Spengos K; Tsivgoulis G; Zis V; Manios E; Vemmos K Blood Press Monit; 2006 Oct; 11(5):235-41. PubMed ID: 16932032 [TBL] [Abstract][Full Text] [Related]
13. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring. Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of white-coat hypertension in a large database of ambulatory blood pressure monitoring. Abir-Khalil S; Zaîmi S; Tazi MA; Bendahmane S; Bensaoud O; Benomar M East Mediterr Health J; 2009; 15(2):400-7. PubMed ID: 19554987 [TBL] [Abstract][Full Text] [Related]
15. Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population. Wang GL; Li Y; Staessen JA; Lu L; Wang JG J Hypertens; 2007 Dec; 25(12):2398-405. PubMed ID: 17984660 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of white-coat response in patients with treated hypertension. MacDonald MB; Laing GP; Wilson MP; Wilson TW CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047 [TBL] [Abstract][Full Text] [Related]
17. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886 [TBL] [Abstract][Full Text] [Related]
18. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?]. Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812 [TBL] [Abstract][Full Text] [Related]
19. Predictors for the white coat effect in general practice patients with suspected and treated hypertension. Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355 [TBL] [Abstract][Full Text] [Related]
20. True resistant hypertension: is it possible to be recognized in the office? Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]